UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 2, 2000
THERMACELL TECHNOLOGIES, INC.
----------------------------
(Exact name of registrant as specified in its character)
Florida 0-21279 59-3223708
- ---------------------------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
440 Fentress Blvd., Daytona Beach, FL. 32114
------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number (including area code): (904) 253-6262
ITEM 4. CHANGES IN COMPANY'S CERTIFYING ACCOUNTANT
The company was formally advised in writing on April 25, 2000, that its
independent certified public accountant firm, Cherry Bekaert & Holland, L.L.P.
was terminating its relationship. The accountants' report on the company's
audited financial statements for the previous two years ended September 30, 1999
and 1998 included limitations based on the assumption that the company would
continue as a going concern. Other than the uncertainty inherent in the going
concern assumption, such financial statements did not contain an adverse opinion
or a disclaimer of opinion nor was it modified as to uncertainty, audit scope or
accounting principles. Further, there have been no disagreements with the former
accountant on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure which disagreement, if not
resolved to the satisfaction of the accountants, would have caused the
accountants to make reference to a disagreement in connection with their reports
during the two most recent fiscal years and the subsequent interim period
through December 31, 1999. No "reportable event", as defined in Item
304(a)(1)(v) of Regulation S-K, occurred during the two most recent fiscal years
and the subsequent interim period through December 31, 1999. The company did not
make any decision to change accountants. A copy of the accountant's letter
appears as an exhibit.
The Registrant's board of directors approved the appointment of Pender Newkirk &
Company as the successor independent accountants to Cherry Bekaert & Holland.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
THERMACELL TECHNOLOGIES,INC.
DATE: May 2, 2000
BY: /s/ Gerald Couture
------------------
Gerald Couture, Vice President Finance
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
- ----------- -----------
16 Accountant's Letter dated May 2, 2000.